Table 2
Best response to tipifarnib treatment
.
Response
.
CR
.
PR
.
HI
.
SD
.
PD
.
NE
.
Patients, no. (%)
22 (14)
3 (2)
12 (8)
50 (32)
58 (37)
13 (8)
.
Response
.
CR
.
PR
.
HI
.
SD
.
PD
.
NE
.
Patients, no. (%)
22 (14)
3 (2)
12 (8)
50 (32)
58 (37)
13 (8)
NE indicates not evaluable.
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal